Tag - medicine

 
 

MEDICINE

Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
COMMENTARY / World
Nov 16, 2020
A vaccine won't derail the easy money train
Don't get carried away by the good news on vaccine development. Central banks are miles from the exit ramp for the tremendous stimulus they've pumped into the economy.
Japan Times
WORLD
Nov 16, 2020
U.S. doctors are calling it quits under stress of the pandemic
Thousands of medical practices have closed during the pandemic, according to a July survey of 3,500 doctors by the Physicians Foundation, a nonprofit group.
Japan Times
COMMENTARY / World
Nov 15, 2020
Here’s to the immigrant heroes behind the BioNTech vaccine
Their journey as Turkish Germans cannot have been easy. Discrimination, overt or subtle, is rife in German society.
Japan Times
JAPAN / Media / MEDIA MIX
Nov 14, 2020
Subsidizing fertility treatment leaves Japanese gynecologists in a bind
Fertility treatments are not covered by national health insurance because, in most cases, infertility is not defined as an ailment.
Japan Times
COMMENTARY / World
Nov 13, 2020
What happens to the other COVID-19 vaccines now?
If the vaccine created by Pfizer and partner BioNTech fails to live up to its promise, will any slower but better competitors have a chance?
Japan Times
ASIA PACIFIC
Nov 13, 2020
China under pressure to reveal vaccine data after Pfizer success
While Beijing has hailed the progress on its own own COVID-19 vaccines, it has so far yet to back this up with evidence.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Moderna COVID-19 vaccine trial reaches key goal to gauge merit
The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Russia says its Sputnik V COVID-19 vaccine is 92% effective
Experts welcomed the news but warned that the results were only based on a small number of trial volunteers who had contracted COVID-19.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Brazil says Chinese vaccine trial can resume after suspension
Brazil health regulator Anvisa on Wednesday allowed resumption of late-stage Brazilian clinical trials for China's Sinovac COVID-19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide.
Japan Times
WORLD
Nov 11, 2020
Brazil halts trial of Chinese vaccine. But was science or politics to blame?
Brazil's health regulator provided little information on its decision to suspend the trial, including whether a reported adverse reaction was related to the vaccine.
Japan Times
WORLD / Science & Health / FOCUS
Nov 10, 2020
Why Pfizer’s vaccine won't be at the local pharmacy anytime soon
The vaccine's complex and supercold storage requirements are an obstacle for even the most sophisticated hospitals and may impact when and where it is available.
Japan Times
WORLD / Science & Health
Nov 10, 2020
China vaccine trial halted in Brazil after serious adverse event
The final-stage trial of a Chinese front-runner vaccine candidate has been halted in Brazil due to a serious adverse event, the first time that any of the Asian nation’s rapidly developed COVID-19 shots have met with such a setback.
Japan Times
WORLD / Science & Health
Nov 10, 2020
Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle
The vaccine candidate is more than 90% effective based on initial trial results, the drugmaker said Monday.
Japan Times
COMMENTARY / World
Nov 7, 2020
The potential for a policy failure on vaccines is huge
Leaders must make decisions about who will get a coronavirus shot first and provide adequate explanations to those denied the vaccine.
Japan Times
WORLD / Politics
Nov 5, 2020
Five U.S. states pass legal marijuana measures
Legal marijuana is becoming the American norm as ballot measures passed in Arizona, Mississippi, Montana, New Jersey, and South Dakota, adding to the 44 states that already allow it for medical or recreational purposes.
Japan Times
WORLD / Science & Health
Nov 4, 2020
Oxford COVID-19 vaccine trial results due this year but not there yet, trial chief says
A vaccine that works is seen as a game-changer in the battle against the coronavirus, which has killed more than 1.2 million people worldwide.
Japan Times
COMMENTARY / World
Nov 4, 2020
Can humanity grow up?
Whether humanity survives this critical period is ultimately up to us. Because the greatest risks are not from nature but from our own action.
Japan Times
ASIA PACIFIC / Science & Health
Nov 4, 2020
China’s race for COVID-19 vaccine raises safety questions
Process has been unhindered by common scientific setbacks being reported by Western rivals, raising questions about how stringently they are vetting potential issues.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?